December 21, 2017 / 1:10 PM / 9 months ago

BRIEF-Trovagene Announces Activation Of Second Clinical Trial Site In Phase 1B/2 Acute Myeloid Leukemia Trial

Dec 21 (Reuters) - Trovagene Inc:

* TROVAGENE ANNOUNCES ACTIVATION OF SECOND CLINICAL TRIAL SITE IN PHASE 1B/2 ACUTE MYELOID LEUKEMIA (AML) TRIAL FOR PCM-075

* TROVAGENE INC - ACTIVATION OF SECOND CLINICAL TRIAL SITE FOR ITS PHASE 1B/2 MULTICENTER TRIAL OF PCM-075 IN PATIENTS WITH AML Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below